Technical Analysis for IMTX - Immatics N.V.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
NR7 | Range Contraction | -1.50% | |
50 DMA Support | Bullish | -1.42% | |
Bullish Engulfing | Bullish | -1.42% | |
Hammer Candlestick | Bullish | -1.42% | |
Stochastic Reached Oversold | Weakness | -1.42% | |
Oversold Stochastic | Weakness | -1.42% | |
20 DMA Resistance | Bearish | -0.59% | |
50 DMA Support | Bullish | -0.59% | |
Down 3 Days in a Row | Weakness | -0.59% |
Alert | Time |
---|---|
10 DMA Resistance | about 17 hours ago |
50 DMA Support | about 17 hours ago |
Down 2 % | about 17 hours ago |
Fell Below Previous Day's Low | about 18 hours ago |
Down 1% | about 18 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/19/2024
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCER™). Its therapeutic approaches are ACTengine, Next Generation ACT, and TCER. The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Treatment Of Cancer Cancer Treatment Cell Therapy Virotherapy Immunotherapies T Cell Adoptive Cell Transfer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Treatment Of Cancer Cancer Treatment Cell Therapy Virotherapy Immunotherapies T Cell Adoptive Cell Transfer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.16 |
52 Week Low | 5.9 |
Average Volume | 521,397 |
200-Day Moving Average | 10.96 |
50-Day Moving Average | 11.78 |
20-Day Moving Average | 12.19 |
10-Day Moving Average | 12.08 |
Average True Range | 0.48 |
RSI (14) | 47.37 |
ADX | 13.11 |
+DI | 16.65 |
-DI | 17.66 |
Chandelier Exit (Long, 3 ATRs) | 11.71 |
Chandelier Exit (Short, 3 ATRs) | 12.35 |
Upper Bollinger Bands | 12.83 |
Lower Bollinger Band | 11.55 |
Percent B (%b) | 0.22 |
BandWidth | 10.56 |
MACD Line | 0.10 |
MACD Signal Line | 0.19 |
MACD Histogram | -0.0922 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.33 | ||||
Resistance 3 (R3) | 12.36 | 12.22 | 12.24 | ||
Resistance 2 (R2) | 12.22 | 12.10 | 12.21 | 12.21 | |
Resistance 1 (R1) | 12.03 | 12.02 | 11.96 | 12.00 | 12.19 |
Pivot Point | 11.89 | 11.89 | 11.86 | 11.88 | 11.89 |
Support 1 (S1) | 11.70 | 11.77 | 11.63 | 11.67 | 11.47 |
Support 2 (S2) | 11.56 | 11.69 | 11.55 | 11.45 | |
Support 3 (S3) | 11.37 | 11.56 | 11.42 | ||
Support 4 (S4) | 11.34 |